Pharmacological approaches to treating addiction are evolving rapidly, with growing evidence supporting the efficacy of medication-assisted interventions for diverse substances. Pharmacotherapy and medication-assisted treatment have transformed recovery trajectories for individuals struggling with opioids, alcohol, and even nicotine. Agents like buprenorphine, methadone, and naltrexone help mitigate withdrawal symptoms and reduce cravings while stabilizing long-term outcomes. Integration of behavioral support enhances the efficacy of these medications, providing a more comprehensive care pathway. Clinicians now focus on individualized treatment planning, ensuring the right pharmacological support is matched with the patient's physiological and psychological needs. As stigma diminishes, accessibility and adherence rates continue to improve.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : What to do when a tragedy strikes
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Genetic decoupling and global regulatory failure in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : An unusual perspective for understanding and preventing bulimia relapse: Unhealthy sibling loyalty
Karen Gail Lewis, Private Practice, United States